NewslettersIntestinal Cell NewsMetabolomics Window into the Diagnosis and Treatment of Inflammatory Bowel Disease in Recent 5 YearsBy Jamie Kang - December 1, 20220149The authors sum up the recent progress of metabolomics in helping to diagnose and treat inflammatory bowel diseases (IBD), hoping to provide biomarkers and new targets for the diagnosis and treatment of IBD.[International Immunopharmacology]Abstract